ING Relative Valuation
ING's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ING is overvalued; if below, it's undervalued.
Historical Valuation
ING Groep NV (ING) is now in the Fair zone, suggesting that its current forward PE ratio of 8.05 is considered Fairly compared with the five-year average of 8.12. The fair price of ING Groep NV (ING) is between 17.88 to 26.82 according to relative valuation methord.
Relative Value
Fair Zone
17.88-26.82
Current Price：20.64
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.07
P/B
Median3y
0.78
Median5y
0.74
-108.73
FCF Yield
Median3y
-16.01
Median5y
-5.22
Competitors Valuation Multiple
The average P/S ratio for ING's competitors is 2.17, providing a benchmark for relative valuation. ING Groep NV Corp (ING) exhibits a P/S ratio of 2.28, which is 4.83% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
ING.N
ING Groep NV
2.28
Average P/S: 2.17
63.91B
LYG.N
Lloyds Banking Group PLC
2.27
56.35B
USB.N
US Bancorp
2.19
3.03%
64.69B
PNC.N
PNC Financial Services Group Inc
Loss
6.05%
65.52B
NWG.N
NatWest Group plc American Depositary Shares, (each representing two (2) Ordinary Shares)
2.46
15.45%
52.51B
COF.N
Capital One Financial Corp
1.65
6.08%
71.93B
People Also Watch
HAIN
Hain Celestial Group Inc
3.030
USD
+3.77%
ORGO
Organogenesis Holdings Inc
5.280
USD
+6.45%
METC
Ramaco Resources Inc
10.000
USD
+0.50%
ORKA
Oruka Therapeutics Inc
10.710
USD
+6.14%
TBPH
Theravance Biopharma Inc
10.370
USD
-0.19%
DDD
3D Systems Corp
2.010
USD
+6.35%
CYH
Community Health Systems Inc
2.830
USD
+2.54%
YRD
Yiren Digital Ltd
6.380
USD
-2.60%
SOHU
Sohu.com Ltd
11.510
USD
+1.77%
ATXS
Astria Therapeutics Inc
5.360
USD
+3.88%
FAQ
Is ING Groep NV (ING) currently overvalued or undervalued?
ING Groep NV (ING) is now in the Fair zone, suggesting that its current forward PE ratio of 8.05 is considered Fairly compared with the five-year average of 8.12. The fair price of ING Groep NV (ING) is between 17.88 to 26.82 according to relative valuation methord.
What is ING Groep NV (ING) fair value?
How does ING's valuation metrics compare to the industry average?
What is the current P/B ratio for ING Groep NV (ING) as of May 03 2025?
What is the current FCF Yield for ING Groep NV (ING) as of May 03 2025?
What is the current Forward P/E ratio for ING Groep NV (ING) as of May 03 2025?